Featured Research

from universities, journals, and other organizations

Homocysteine: A Possible Risk Factor For Alzheimer's Disease

Date:
May 4, 1998
Source:
University Of Oxford
Summary:
Scientists at the Universities of Oxford, in the UK, and Bergen, Norway, have found an association between pathologically-confirmed Alzheimer's disease and moderately elevated blood levels of the amino acid, homocysteine. A moderate elevation in blood levels of homocysteine is a known risk factor for heart disease and stroke.

Scientists at the Universities of Oxford, in the UK, and Bergen, Norway, have found an association between pathologically-confirmed Alzheimer's disease and moderately elevated blood levels of the amino acid, homocysteine. A moderate elevation in blood levels of homocysteine is a known risk factor for heart disease and stroke.

Researchers found that 76 patients in the Oxford Project to Investigate Memory and Ageing (OPTIMA) who had pathologically-confirmed Alzheimer's disease had elevated blood levels of homocysteine and lower blood levels of folate and vitamin B12 (the vitamins which control homocysteine levels) than 108 age-matched control subjects.

These latest findings, which have yet to be published, were reported yesterday (Monday 27 April) in Nijmegen, Netherlands, at the second International Conference on Homocysteine Metabolism. However, the authors of the report, `Hyperhomocysteinemia: an independent risk factor for histopathologically-confirmed Alzheimer's disease - Professor David Smith, Dr R Clarke, Dr K A Jobst, Ms L Sutton, Professor P M Ueland, and Professor H Refsum - stressed that these biochemical changes in the blood could be a consequence, rather than a cause, of Alzheimer's disease, and that further work is required to distinguish between these two interpretations.

In particular, clinical trials over a number of years will be needed to determine if lowering homocysteine levels, by means of dietary supplementation with folic acid and vitamin B12, influences the development of Alzheimer's disease. Individuals should not take extra folic acid without consulting their doctor.

Profesor David Smith, Chairman of the Department of Pharmacology at Oxford and head of OPTIMA, said: `These findings are important because they provide a testable hypothesis that it may be possible to prevent or delay the progression of Alzheimer's disease in a proportion of potential sufferers. However, testing this hypothesis will require long and costly trials.'

A full paper describing the results of this study is being considered for publication in a medical journal, and no further details of the research will be issued until the date of publication.

The study has been supported by a long-term grant to the University of Oxford's Department of Pharmacology by Bristol-Myers Squibb Co, and to the Department of Pharmacology at the University of Bergen from the Norwegian Council on Cardiovascular Disease.

Since its foundation in 1988, OPTIMA has been conducting research into changes which occur in the brain as part of the ageing process. In revealing the differences between normal brain ageing and diseases like Alzheimer's disease, OPTIMA aims to lay the foundations for the development of new forms of prevention and treatment.

The project's work was examined in two hour-long documentaries, `Assault on the Mind', shown on Channel 4 in the UK on April 21 and 28. The programme outlined the methods and main achievements of OPTIMA, including:

* Development of an accurate diagnostic procedure for Alzheimer's disease in life by a combination of structural and functional brain imaging.

* Discovery of a biological `state' marker, the thickness of the medial temporal lobe, that can be used to follow the progression of Alzheimer's disease.

Notes to editors: No interviews or further comments will be given by members of the OPTIMA team until publication of the full paper. More details about OPTIMA's research are available on the OPTIMA website at http://www.pharm.ox.ac.uk/optima.htm

Any additional queries should be addressed to the University Press Office on 01865 278181/2/3.


Story Source:

The above story is based on materials provided by University Of Oxford. Note: Materials may be edited for content and length.


Cite This Page:

University Of Oxford. "Homocysteine: A Possible Risk Factor For Alzheimer's Disease." ScienceDaily. ScienceDaily, 4 May 1998. <www.sciencedaily.com/releases/1998/05/980504125421.htm>.
University Of Oxford. (1998, May 4). Homocysteine: A Possible Risk Factor For Alzheimer's Disease. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/1998/05/980504125421.htm
University Of Oxford. "Homocysteine: A Possible Risk Factor For Alzheimer's Disease." ScienceDaily. www.sciencedaily.com/releases/1998/05/980504125421.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins